Organovo Holdings, Inc. (ONVO)
NASDAQ: ONVO · Real-Time Price · USD
0.369
-0.010 (-2.61%)
Feb 21, 2025, 4:00 PM EST - Market closed
Organovo Holdings Market Cap
Organovo Holdings has a market cap or net worth of $5.67 million as of February 21, 2025. Its market cap has decreased by -37.69% in one year.
Market Cap
5.67M
Enterprise Value
5.57M
1-Year Change
-37.69%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since February 14, 2012, Organovo Holdings's market cap has decreased from $11.20M to $5.67M, a decrease of -49.38%. That is a compound annual growth rate of -5.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 6.40M | -9.86% |
Dec 31, 2024 | 7.10M | -27.55% |
Dec 29, 2023 | 9.80M | -20.33% |
Dec 30, 2022 | 12.30M | -61.08% |
Dec 31, 2021 | 31.60M | -61.84% |
Dec 31, 2020 | 82.80M | 78.45% |
Dec 31, 2019 | 46.40M | -58.16% |
Dec 31, 2018 | 110.90M | -22.61% |
Dec 29, 2017 | 143.30M | -59.30% |
Dec 30, 2016 | 352.10M | 53.02% |
Dec 31, 2015 | 230.10M | -60.58% |
Dec 31, 2014 | 583.70M | -31.77% |
Dec 31, 2013 | 855.50M | 600.66% |
Dec 31, 2012 | 122.10M | 990.18% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |